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Abstract
Significance: Hydrogen sulfide (H2S), produced by the desulfuration of cysteine or homocysteine, functions as a
signaling molecule in an array of physiological processes including regulation of vascular tone, the cellular stress
response, apoptosis, and inflammation. Recent Advances: The low steady-state levels of H2S in mammalian cells
have been recently shown to reflect a balance between its synthesis and its clearance. The subversion of enzymes
in the cytoplasmic trans-sulfuration pathway for producing H2S from cysteine and/or homocysteine versus
producing cysteine from homocysteine, presents an interesting regulatory problem. Critical Issues: It is not
known under what conditions the enzymes operate in the canonical trans-sulfuration pathway and how their
specificity is switched to catalyze the alternative H2S-producing reactions. Similarly, it is not known if and
whether the mitochondrial enzymes, which oxidize sulfide and persulfide (or sulfane sulfur), are regulated to
increase or decrease H2S or sulfane-sulfur pools. Future Directions: In this review, we focus on the enzymology
of H2S homeostasis and discuss H2S-based signaling via persulfidation and thionitrous acid. Antioxid. Redox
Signal. 20, 770–782.
Hydrogen Sulfide Biogenesis
In mammals, hydrogen sulfide (H2S) is primarily producedby enzymes of the trans-sulfuration pathway, cystathionine
b-synthase (CBS), and cystathionine c-lyase (CSE) (11, 34, 71)
(Fig. 1). A third enzyme, 3-mercaptopyruvate sulfurtransfer-
ase (MST) can also contribute to endogenous H2S production
in the presence of reductants using 3-mercaptopyruvate as a
substrate (47, 67). Despite the high level of interest in the
physiological effects of H2S, the regulation of its biogenesis is
poorly understood.
In addition to H2S generation, the trans-sulfuration path-
way enzymes are responsible for the synthesis of cysteine
from homocysteine. The intracellular concentration of cyste-
ine varies from 90 to 100 lM in most tissues (85) but is higher
in the kidney (*1mM) (74). Cysteine has multiple metabolic
fates and in addition to H2S biogenesis, can be directed to the
synthesis of glutathione and taurine whose steady-state
concentrations can reach up to 10 and 20mM, respectively
(84–86). In contrast, the steady-state concentration of H2S is
estimated to be in the low nanomolar range in most tissues
(17, 87) with the exception of aorta, where it is *20- to
100-fold higher (41). Recent kinetic studies have indicated that
the flux of sulfur into H2S is high and comparable to that
directed into the glutathione pathway in liver (87). Hence, the
low steady-state concentration of H2S reflects a high rate of
clearance and/or consumption (87).
It is estimated that *50% of the cysteine used for hepatic
glutathione synthesis is derived from methionine via the
trans-sulfuration pathway (4, 50). Genetic deficiency of CBS,
the first enzyme in the trans-sulfuration pathway, causes
homocystinuria characterized by multisystem complications
involving the cardiovascular, neuronal, central nervous, and
ocular systems (51). Further, connective tissue disorders in
these patients are attributed to cysteine deficiency indicating
the importance of the trans-sulfuration pathway in supplying
cells with cysteine (42). Hence, understanding how allocation
of cysteine and homocysteine into alternative metabolic
pathways is gated is essential for understanding how cysteine
is apportioned to meet intracellular needs. In particular, since
the canonical trans-sulfuration pathway uses homocysteine
and serine to generate cysteine, it is particularly important to
understand how the same catalysts are subverted to generate
H2S from cysteine and homocysteine and under what cir-
cumstances. Regulation of H2S generation is expected to be
one mechanism for augmenting or diminishing its levels on
demand. In the following section, the enzymology of H2S
generation by CBS, CSE, and MST is discussed.
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H2S generation by CBS
CBS catalyzes the first and committing step in the trans-
sulfuration pathway, that is, the b-replacement of serine with
homocysteine to form cystathionine and water. When cyste-
ine replaces serine as a substrate, the reaction products are
cystathionine and H2S instead. CBS also catalyzes additional
reactions that produce H2S from cysteine (Fig. 2), that is,
b-replacement of cysteine by water to form serine and
b-replacement of cysteine by a second mole of cysteine to
produce lanthionine. In both these reactions, H2S is elimi-
nated. Of these, the b-replacement of cysteine with homo-
cysteine is kinetically the most efficient H2S-producing
reaction (71). Serine (560lM) is more abundant inside the cell
than cysteine and human CBS exhibits a lower KM for serine
(2mM) than for cysteine (6.8mM) (71, 77). Hence, serine is
expected to be the substrate of choice for CBS. It is not known
if and how the substrate preference for CBS can be switched
from serine to cysteine to promote its involvement in the
trans-sulfuration pathway versus in H2S generation.
The activity of CBS appears to be highly regulated. Unlike
other known pyridoxal 5¢-phosphate (PLP)-dependent en-
zymes, CBS contains a regulatory heme cofactor (Fig. 3a) that
functions as a redox-dependent gas sensor (35, 63, 76, 78). The
heme in CBS exists in two oxidation states: ferric (Fe+3) and
ferrous (Fe+ 2). Ferrous CBS can bind the gas signaling mole-
cules, CO andNO, resulting in inhibition of its catalytic activity
(76, 78). Air oxidation of the ferrous-COor ferrous-NO forms of
CBS leads to recovery of the ferric heme state and of enzyme
activity (Fig. 4).
The relatively low potential of the Fe + 3/Fe+ 2 redox couple
for the heme (- 350– 4mV) in CBS (70) begs the question
as to whether redox modulation of CBS has physiological
relevance. In this context, the recent demonstration that CBS
can be reduced by a cytoplasmic diflavin oxidoreductase like
methionine synthase reductase is important (35). In the pres-
ence of CO and methionine synthase reductase, the inhibitory
ferrous-CO CBS species is formed showing that this mode of
redox regulation is physiologically accessible. Further, mod-
ulation of CBS activity by NO or CO provides a mechanism
for crosstalk between these gas signaling systems. A physio-
logically important context for CO regulation is the regulation
of cerebral blood flow under normoxic versus hypoxic con-
ditions, a protective mechanism to maintain adequate supply
of oxygen to brain, which is reportedly mediated by modu-
lation of H2S production of CBS by CO (49).
CBS is allosterically activated by S-adenosylmethionine
(SAM), a universal methyl group donor involved in numerous
methylation reactions (16), which binds to the C-terminal reg-
ulatory domain of the protein (Fig. 3a). SAMplays a central role
in sulfur metabolism by mobilizing the methyl group of me-
thionine and making the sulfur containing amino acid homo-
cysteine, available for recycling via transmethylation or for
trans-sulfuration. By also regulating CBS, SAM plays a critical
role in coordinating regulation of methylation and redox ho-
meostasis. SAM enhances b-replacement by homocysteine of
both serine and cysteine (71). In addition to functioning as an
allosteric activator, SAM also stabilizes CBS (62). Under path-
ological conditions where SAM levels are depressed, destabili-
zation of CBS serves as a mechanism for redirecting sulfur
metabolic flux toward methionine conservation.
Another mode of regulation of CBS is by post-translational
modification by small ubiquitin-like modifier (SUMO) pro-
tein, which is correlated with the localization of CBS in the
FIG. 1. Pathways for H2S production and oxidation. H2S biogenesis catalyzed by the trans-sulfuration pathway enzymes,
CBS and CSE occurs in the cytoplasm. The AAT/MST pathway exists in the cytoplasm and in the mitochondrion. Sulfide is
oxidized in the mitochondrion by SQR to generate persulfide. In the second step, the persulfide is oxidized by ETHE1, a
dioxygenase, to generate sulfite that can either be oxidized by rhodanese or by sulfite oxidase. Electrons released in the SQR
reaction are captured by ubiquinone and transferred to the electron transport chain at the level of complex III. AAT, aspartate
aminotransferase; CBS, cystathionine b-synthase; CSE, cystathionine c-lyase (c-cystathionase); ETHE1, sulfur or persulfide
dioxygenase; SQR, sulfide quinone oxidoreductase; H2S, hydrogen sulfide. To see this illustration in color, the reader is
referred to the web version of this article at www.liebertpub.com/ars
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FIG. 2. H2S-generating reactions catalyzed
by CBS, CSE, and AAT/MST. The trans-
sulfuration enzymes, CBS and CSE catalyze
multiple H2S-generating reactions. The ca-
nonical reaction catalyzed by each enzyme in
the trans-sulfuration pathway is shown at the
top of the respective group. The AAT/MST
pathway involves an initial transamination
reaction followed by a sulfur transferase re-
action. MST, mercaptopyruvate sulfur-
transferases.
FIG. 3. Structures of H2S-producing enzymes. (a) The structure of full-length dimeric Drosophila CBS showing the lower
catalytic domains containing PLP and heme and the upper regulatory subunits (PDB file 3PC4). The heme and PLP shown in
stick representation, bind to the catalytic domains while SAM binds to the regulatory domain. (b) Structure of homo-
tetrameric human CSE in which the subunits are shown in different shades (PDB file 2NMP). PLP is seen in three of the four
subunits and is shown in ball representation. The two CXXC motifs are shown in sphere representation in one of the subunits.
(c) Structure of human MST (PDB file 3OLH). The active site cysteine (Cys248) that is modified as a persulfide is shown in
sphere representation. SAM, S-adenosylmethionine; PLP, pyridoxal 5¢-phosphate. To see this illustration in color, the reader is
referred to the web version of this article at www.liebertpub.com/ars
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nucleus (1, 36). Sumoylation of CBS is sensitive to the con-
centration of its substrates and leads to diminished catalytic
activity (1). However, the mechanism by which sumoylation
affects CBS activity and whether this regulatory strategy is
pertinent to H2S production are not known.
The trans-sulfuration pathway is regulated in response to
various triggers such as hormones and conditions that lead to
elevated cyclic AMP levels (19). Streptozotocin-induced dia-
betic rats exhibit increased hepatic CBS expression and ac-
tivity, which was also seen in glucocorticoid-stimulated rat
hepatoma cells (65). Insulin treatment reduced CBS expres-
sion in both the streptozotocin rat model and in glucocorti-
coid-treated cells. In mouse kidney, CBS is regulated by
testosterone andmales exhibit*threefold higher CBS activity
than females, which is correlated with a similar difference in
CBS protein levels (88). Interestingly, a range of regulatory
patterns for renal CBS is seen in mammals: females exhibit
higher CBS activity in humans and rats but lower activity in
mice, while gender-specific differences are not seen in rabbit,
hamster, and guinea pig (88). In the human prostate cancer
cell line LNCaP, testosterone downregulates CBS via a post-
transcriptional mechanism and results in lower flux through
the trans-sulfuration pathway and lower glutathione levels
(61). CBS is also post-translationally activated in response to
oxidative stress, resulting in *twofold increase in flux
through the trans-sulfuration pathway (50). However, the
molecular mechanism of this upregulation and its pertinence
to H2S generation are not yet known.
H2S generation by CSE
The canonical role of CSE in the trans-sulfuration pathway
is to cleave cystathionine forming cysteine, ammonia, and
a-ketobutyrate. CSE is a homotetrameric enzyme (Fig. 3b) and
can catalyze various other reactions to generate H2S from
cysteine (Fig. 2). Unlike CBS, homocysteine alone serves as an
H2S-generating substrate for CSE. The relaxed substrate
specificity of CSE allows accommodation of cystathionine,
cysteine, and homocysteine in the same binding pocket where
they compete for forming a Schiff base with PLP. In contrast,
homocysteine does not bind to the PLP site in CBS. Consistent
with this observation, H2S production by CSE but not CBS is
sensitive to homocysteine concentrations (71). Hence, with
increasing concentrations of homocysteine, as seen in homo-
cystinuric patients, the contribution of this substrate to H2S
formation is predicted to increase progressively (71).
CSE is believed to be themajor endogenous source of H2S in
peripheral tissues as CSE knockout mice have low serum H2S
levels (95). In brain, CSE levels are relatively low, at least in
mice andCBS is believed to be the primary producer ofH2S (13,
89). Brain H2S levels were essentially unchanged in CSE
knockout mice (95). However, a commonly overlooked factor
that could potentially lead to underestimation of the contri-
bution of CBS is that it produces H2S preferentially from
homocysteine+ cysteine, whereas the preferred route for H2S
production by CSE requires only cysteine (71). Since cysteine is
employed as the sole substrate in most assays with cell and
tissue extracts, the full contribution of CBS is missed. Hence,
the significance of CBS in H2S production in peripheral tissues
is routinely underestimated and requires further investigation.
An additional reason why the contribution of CBS to H2S
productionmight have been underestimated in CSE knockout
mice is the following. CSE is required for cysteine synthesis via
the trans-sulfuration pathway and disruption of its gene also
deprives CBS of one of the substrates needed for H2S pro-
duction. Hence, both CSE and CBS-dependent H2S produc-
tion is affected by disruption of the CSE gene. In contrast,
disruption of the CBS gene leads to accumulation of homo-
cysteine, a substrate for H2S production by CSE (11). Given
the complexity and the multitude of H2S-generating reactions
catalyzed by CBS and CSE (Fig. 2), special attention must be
paid to the assay design and data interpretation. Specifically,
it is important to assess H2S generation in the presence of
cysteine versus cysteine +homocysteine to more fully estimate
the contributions of both enzymes.
Regulation of CSE is not well understood. Human CSE is a
tetramer with a subunit molecular mass of 45 kDa. Each
subunit contains twoCXXCmotifs (Fig. 3b) and their ability to
influence CSE activity in a redox-sensitive manner is not
known. Under in vitro conditions, CSE is post-translationally
modified by SUMO (1), a signal that is often used for nuclear
localization. The physiological relevance and the role, if any,
of sumoylation on CSE function is currently unknown. A
twofold increase in CSE activity by calmodulin, albeit in the
presence of high calcium concentration (2mM), has been
reported (95). Our laboratory has not been able to detect
calmodulin-dependent activation of purified recombinant
human CSE and calmodulin from various sources (Padovani
and Banerjee, unpublished results). The relevance of calcium/
calmodulin-dependent regulation of CSE remains open.
CSE expression is upregulated in response to endoplasmic
reticulum (ER) stress in a mechanism dependent on the acti-
vating transcription factor, ATF4 (14). The latter is expressed as
part of the unfolded protein response to alleviate stress damage
(90). The upregulation of CSE correlates well with the*four-
fold increase in H2S production in response to ER stress where
H2S plays a protective role. H2S increases phosphorylation and
activation of protein kinase-like endoplasmic reticulum kinase
(PERK), an ER kinase, by persulfide modification and inacti-
vation of the protein tyrosine phosphatase, PTP1B (40). Acti-
vated PERK leads to inhibition of general protein synthesis by
FIG. 4. Redox-dependent regulation of human CBS by
gases. Ferric CBS can be reduced by NADPH in the presence
of the diflavin methionine synthase reductase to give ferrous
CBS. The latter can react with CO or NO to give ferrous-CO
or ferrous-NO CBS, respectively, which upon air oxidation
revert to ferric CBS. The NO- and CO-liganded forms of CBS
are inactive.
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phosphorylating eukaryotic initiation factor 2a, a common
protective cellular response to stress (22). CSE expression is
increased in liver and pancreas in streptozotocin-induced dia-
betic rats, amodel for type-1 diabetes (30, 97). Insulin treatment
reduced CSE expression (97). CSE is also overexpressed in
pancreatic b-cells in Zucker diabetic fatty rats, amodel for type-
2 diabetes. Addition of the NaHS or cysteine reportedly in-
hibited insulin release from islets and from theMIN6pancreatic
b-cells (37) while H2S production was higher in islets isolated
from Zucker diabetic fatty versus Zucker lean rats (93). On the
other hand, CSE expression is reduced in kidney proximal
tubules in a spontaneous diabetic mouse model (94). CSE ex-
pression is upregulated in response to inflammation by TNFa-
dependent recruitment of the transcription factor specificity
protein 1 (SP1) (66), which binds to the CSE promoter (28).
H2S generation by MST
MST can produce H2S from 3-mercaptopyruvate (67),
which is formed by a transamination reaction between
cysteine and a-ketoglutarate catalyzed by aspartate amino-
transferase (AAT)/cysteine aminotransferase (83) (Fig. 2).
MST uses 3-mercaptopyruvate as a substrate and transfers the
sulfur to a nucleophilic cysteine in the active site (Fig. 3c)
yielding persulfide and pyruvate (Fig. 1). The MST-bound
persulfide is a potential source of H2S in the presence of a
reductant or following transfer to an acceptor such as thior-
edoxin (91) and subsequent reduction.
The KM values for mercaptopyruvate for rat and bovine
MST are 1.2mM (57) and 2.8mM (31), respectively. The ac-
tivity of MST in cysteine degradation and hence in H2S pro-
duction, is gated by transamination of cysteine, which is a side
activity of AAT. While the KM for aspartate is 1.6mM, the KM
for cysteine is 22mM, which is significantly higher (2, 91).
Further, aspartate is a potent inhibitor of cysteine transami-
nation byAAT (2).While the cellular concentration of cysteine
in most tissues is low (*30–100 lM) (74), the concentration of
aspartate is relatively high, *730 lM and 4mM in mouse
liver and brain respectively (Vitvitsky, V. and Banerjee R,
unpublished data). The mitochondrial cysteine concentration
in rat is reported to be*0.7–1mM (82). These numbers would
seem to argue against significant diversion of cysteine to H2S
production via the AAT/MST pathway in the cytosol under
most conditions. However, the contribution of the mito-
chondrial MST pool to H2S production might be more sig-
nificant. The AAT/MST route might also be more significant
for H2S generation in tissues where the cysteine concentration
is high, for example, kidney where cysteine is*1mM (74), or
in tissues with low CBS and/or CSE expression. MST is ex-
pressed in kidney, liver, aorta, and in brain (55). MST is pro-
posed to contribute to H2S production in brain (68) and in
vascular endothelial tissues (67). Unlike CBS and CSE, MST is
localized in the mitochondrion in addition to the cytoplasm
(55, 75), where it might contribute to energy metabolism via
the sulfide oxidation pathway.
The active site of MST has a reactive cysteine residue that is
sensitive to oxidants and represents a switching mechanism
for redox regulation. However, unlike the trans-sulfuration
pathway, MST is inhibited under oxidative stress conditions.
At stoichiometric concentrations of H2O2, the active site
cysteine is converted to cysteine sulfenate with concomi-
tant enzyme inactivation that is reversed by DTT or by a
thioredoxin/thioredoxin reductase system (56). The rationale
for inhibition of MST under oxidative stress conditions is that
it conserves cysteine needed for glutathione synthesis. How-
ever, for this regulation to be a plausible strategy for sparing
cysteine, AAT, the enzyme, which utilizes cysteine to generate
the substrate for MST, mercaptopyruvate, needs to be in-
hibited. While modification of a reactive cysteine residue in
AAT reduced the activity of cytoplasmic AAT (5), no change
in the activity of mitochondrial AAT was observed (18). De-
letion of the AAT1 gene in yeast causes a respiratory defect
and impaired iron homoeostasis with no apparent change in
sensitivity to oxidative stress (72). Rat MST also undergoes
redox-dependent dimerization mediated by intersubunit
disulfide linkage, which is accompanied by inhibition. The
latter is reversed by thioredoxin-dependent reduction (58).
However, this mechanism of redox regulation is not likely to
be pertinent for human MST since the cysteine residues in-
volved in subunit cross-linking in rat MST are not conserved
in the human enzyme.
Catabolism of H2S
Sulfide administered at sublethal concentrations is rapidly
oxidized inmammals and primarily excreted as thiosulfate and
sulfate (12). Metabolic labeling studies with Na2
35S have indi-
cated tissue-specific differences in sulfide catabolism rates and
in product distribution (3). Rat liver converts sulfide primarily
to sulfate, kidney to a mixture of thiosulfate and sulfate, and
lung predominantly to thiosulfate. The sulfide oxidation
pathway resides in the mitochondrion and oxidation of thio-
sulfate to sulfate was shown to be glutathione-dependent.
These early labeling studies established thiosulfate and sulfite
as intermediates in the sulfide oxidation pathway leading to
sulfate (3, 12, 39). Coupling of sulfide catabolism to oxidative
phosphorylation via ubiquinone, makes sulfide the first
known inorganic substrate for the human electron transfer
chain (20). In this section, the enzymology of H2S and per-
sulfide oxidation catalyzed by sulfide quinone oxidoreduc-
tase (SQR) and persulfide dioxgenase (ETHE1), respectively,
is discussed.
H2S oxidation by SQR
SQR gates the entry of H2S into the oxidation pathway
(Fig. 1). SQR belongs to the family of disulfide oxidoreduc-
tases and is found in all three domains of life (79). It is char-
acterized by high substrate affinity and reaction rates. It is an
enzyme with ancient origins and the extant eukaryotic SQRs
are traced to an eubacterial donor from which the common
ancestor of fungi and animals acquired this gene (79). SQRs
are membrane proteins found on the periplasmic side of the
cytoplasmic membrane in bacteria and in the inner mito-
chondrial membrane in eukaryotes. They are monotopic
proteins that might be dimeric or trimeric in the membrane
and harbor a single flavin adenine dinucleotide (FAD) co-
factor in each monomer (Fig. 5a). The crystal structures of
several SQRs have been reported (7, 9, 10, 43) and are char-
acteristic of proteins in the flavin disulfide reductase family.
The structure comprises a C-terminal domain with two am-
phipathic helices considered to be important for membrane
binding and two Rossman fold domains, with the N-terminal
one binding the FAD cofactor. SQRs have a high catalytic
turnover rate and low micromolar KM for sulfide (7, 9, 10).
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The FAD cofactor in SQRs can either be noncovalently
bound to the active site (10, 29) or covalently bound via a
thioether linkage between an active cysteine or a persulfide
and the 8-methylene group of the isoalloxazine ring (7, 43).
The FAD alternates between accepting electrons from sulfide
and donating them to ubiquinone, positioned proximal to the
isoalloxazine ring. Like other flavoprotein disulfide reduc-
tases, SQR harbors a redox-active dithiol/di-sulfide pair on
the re face of the flavin cofactor. A minimal reaction mecha-
nism begins with the attack of sulfide on an active site dis-
ulfide forming a persulfide and liberating a cysteine thiolate
(Fig. 4). The latter attacks the FAD forming a C4A adduct.
Nucleophilic attack of an acceptor on the sulfane sulfur atom
sets up re-formation of a disulfide and a two-electron transfer
to the FAD to give FADH2. Electrons from FADH2 are
transferred to ubiquinone that is positioned on the si side of
the isoalloxazine ring and is bound in a surface-exposed
channel (10).
In bacterial SQR’s, product release does not precede bind-
ing of each mole of sulfide to the active site. Instead, the cat-
alytic cycle repeats until the maximum length of the
polysulfide that can be accommodated in the sulfide oxida-
tion pocket is achieved. Two consecutive nucleophilic attacks
by sulfide restore the original disulfide state of the enzyme
and the release of the polysulfide product. The crystal struc-
ture of theAcidianus ambivalens SQR reveals a trisulfide bridge
between the two active site cysteines while the Acid-
ithiobacillus ferrooxidans protein has been crystallized with a
branched bridge containing five sulfur atoms between the two
cysteines (7, 10). Linear and cyclic polysulfur intermediates of
variable length were seen in the structure of the Aquifex aeo-
licus SQR (43). Spatial constraints within the active site limit
the length of the polysulfide chain, and in bacterial SQRs, the
oxidized sulfur is released as a soluble polysulfide containing
up to ten sulfur atoms (10, 21). In contrast, in mammalian
SQR, the persulfide is transferred to an acceptor at the end of
each catalytic cycle (Fig. 6) (25).
It has been proposed that human SQR utilizes sulfite as the
persulfide acceptor, forming thiosulfate (29). The recombinant
human enzyme exhibits relatively high and similar catalytic
efficiencies with cyanide or sulfite as acceptor but a signifi-
cantly lower efficiency with sulfide as acceptor. However, the
utilization of sulfite as the acceptor in cells poses at least a
couple of problems. The first is teleological since sulfite is the
product of persulfide dioxygenase (ETHE1, also known as
sulfur dioxygenase), which is downstream of SQR in the ox-
idation pathway (Fig. 1). Hence, the production of sulfite is
indirectly dependent on SQR. The second is an incompati-
bility with the clinical data as both H2S and thiosulfate levels
are elevated in patients with ETHE1 deficiency (81). Since
sulfite levels are greatly diminished in this condition, the
observed accumulation of both the substrate (H2S) and pu-
tative product (thiosulfate) of the SQR reaction is not ex-
plained in these patients. Sulfite can be generated from
cysteine catabolism via the successive action of cysteine di-
oxygenase and a transaminase to give cysteine sulfinic acid
FIG. 6. Minimal mechanism for the reaction catalyzed by human SQR. An active site disulfide is attacked by the
incoming sulfide nucleophile and gives a persulfide and a free active site cysteine. The latter attacks the bound flavin forming
a 4a adduct. Nucleophilic displacement by an acceptor (A) results in the transfer of the sulfane sulfur atom, reformation of the
active site disulfide, and a two-electron reduction of the flavin.
FIG. 5. Structures of en-
zymes in the sulfide oxida-
tion pathway. Structures of (a)
SQR from the hyperthermo-
philic bacterium Aquifex aeoli-
cus (PDB file: 3HYW) and (b)
Arabidopsis ETHE1 (PDB fi-
le:2GCU) showing the mono-
nuclear nonheme iron (sphere)
in the active site. The three
subunits of SQR are shown in
different shades and the FAD is
shown in stick representation
in (a). FAD, flavin adenine
dinucleotide. To see this illus-
tration in color, the reader is
referred to the web version of
this article at www.liebertpub
.com/ars
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and b-sulfinylpyruvate, respectively followed by the decom-
position of b-sulfinylpyruvate to sulfite and pyruvate (69, 73).
However, the contribution of this pathway to sulfite pro-
duction is expected to be minor under normal conditions but
upregulated only under conditions of cysteine excess. Third,
variants of ETHE1 are found in nature, which are fused to the
sulfurtransferase, rhodanese. While this remains to be estab-
lished, this genetic organization suggests that it increases the
efficiency of utilization of sulfite, the product of the ETHE1
reaction, by rhodanese. Based on these considerations, the
identity of the persulfide acceptor of mammalian SQRs re-
mains to be established.
Persulfide dioxygenase (ETHE1)
ETHE1 is a soluble non-heme iron-containing sulfur diox-
ygenase (Fig. 5b) (46, 81) and is proposed to catalyze the
second step in the mitochondrial sulfide oxidation pathway,
that is, oxygenation of persulfide formed from H2S by SQR
giving sulfite (25). It is not known if ETHE1 directly acts on the
persulfide formed on SQR or indirectly following transfer of
the SQR-bound persulfide to a small molecule carrier. Under
in vitro assay conditions, glutathione persulfide serves as a
substrate for ETHE1 (25, 81) exhibiting a KM value of
0.31 – 0.03mM for the rat (25) and 0.34 – 0.03mM for the
human (33) protein. Coenzyme A persulfide serves as an al-
ternate, albeit poor substrate for human ETHE1 while the
persulfides of cysteine and homocysteine do not elicit dioxy-
genase activity (33).
Mutations in ETHE1 result in ethylmalonic encephalopathy
(EE), an autosomal recessive disorder characterized with se-
vere pathophysiological abnormalities leading to death in the
first decade of life (80). Over 20 pathogenic mutations have
been described in EE patients (48). ETHE1 knockout mice
have increased H2S levels, 20-fold higher than in wild-type
mice and low steady-state levels and activity of cytochrome c
oxidase in luminal colonocytes, muscle and brain. Liver ex-
tracts from knockout mice exhibit threefold lower sulfide-
dependent oxygen consumption and the animals die within
5–6 weeks after birth (81).
Interestingly, both ethe1-/- mice and patients with EE
show increased levels of thiosulfate (81), which is puzzling
since thiosulfate is postulated to be produced downstream of
ETHE1 in the sulfide oxidation pathway. One explanation of
this observation is that the persulfide generated by SQR is
transferred to sulfite to form thiosulfate in a reaction catalyzed
by rhodanese (Fig. 1), and that this reaction is enhanced in the
absence of competition for the persulfide by ETHE1. As dis-
cussed above, the cysteine oxidation pathway represents an
alternate route for generation of sulfite (69, 73). However, it is
not known whether this pathway is a significant contributor
of sulfite under conditions of ETHE1 deficiency.
The detailed reaction mechanism of ETHE1 remains to be
elucidated. The structure of the Arabidopsis ETHE1 reveals a
dimeric protein with an active site iron coordinated by a 2-
His-1-Asp facial triad (Fig. 5b) (46), a coordination geometry
seen in a number of mononuclear non-heme iron(II) oxyge-
nases (38). Although diverse, these enzymes share common
elements in their reaction mechanisms. In most cases, the
substrate and dioxygen bind to the active site iron(II). Oxygen
activation progresses through internal electron transfer to
form various intermediates, for example, the Fe(III)-superoxo
and the Fe(III)-peroxo species. O-O bond cleavage then leads
to formation of a high valent oxyferryl (Fe + 4 =O) species (45,
52, 64, 96) that is believed to be a key oxidant for substrate
oxidation. In some dioxygenases, the substrate binds close to
the iron center and the carboxylate of the facial triad functions
as a bidentate ligand (38).
ETHE1 catalyzes a relatively distinct reaction from other
members of the mononuclear iron-dependent dioxygenase
superfamily, that is, the oxidation of the sulfane sulfur of a
persulfide substrate (33) (Fig. 7). A similar reaction is cata-
lyzed by cysteine dioxygenase (96), a cupin family dioxy-
genase, which oxidizes the sulfur of cysteine to form cysteine
sulfinic acid, the first step in the cysteine degradation path-
way. Yet, cysteine dioxygenase is different from the 2-His-1-
carboxylate family in that all three protein-provided iron
ligands in cysteine dioxygenase are histidine residues (45).
Since the activity of ETHE1 is oxygen dependent, it is possible
that its activity is downregulated under hypoxic conditions.
Sulfane Sulfur as an H2S Store?
In principle, cells can harbor sulfide stores for mobilization
in response to triggers, thus setting off H2S-dependent signal-
ing. Sulfide can be stored as sulfane sulfur in which sulfur is
covalently bonded to another sulfur atom. Examples of sulfane
sulfur include protein-bound polysulfide (Protein-S-Sn-S-
Protein) and persulfide, (Protein-S-SH) while examples of low-
molecular weight compounds include inorganic polysulfide
(R-Sn-R, where n‡ 3) and polythionate (-O3S-Sn-SO3- , where
n‡ 1), thiosulfate (S2O32- ) and elemental sulfur (S8).
Estimates of the sulfane sulfur pool size in rat tissues have
furnished values of 324, 41, 34, and 19 nmol g - 1 kidney, liver,
spleen, and brain, respectively (60). Subcellular fractionation
of liver and kidney revealed that approximately half of this
pool is located in the cytoplasm. In HEK293 cells, the bound
sulfur pool size (*0.15 nmol mg- 1 protein) reportedly in-
creased *twofold in the presence of cysteine by over-
expression of AAT/MST but not CBS (60). In a separate study,
transfection of HEK293 cells with CSE enhanced protein
S-sulphydration in the presence of cysteine (53). It is impor-
tant to again emphasize that the choice of the H2S generat-
ing substrate used in studies can bias results about the
contribution of the various H2S generating pathways. Hence,
provision of exogenous cysteine stimulates CSE- and MST-
dependent H2S biogenesis, whereas CBS-dependent H2S
production is stimulated in the presence of cysteine and
homocysteine (8, 11, 71).
FIG. 7. Overall reaction catalyzed by ETHE1. The resting
form of the enzyme has water molecules coordinated to the
vacant ligand sites at the 3-His-1-Asp mononuclear ferrous
iron site. Binding of the substrate persulfide displaces the
water molecules. Iron-based oxidation chemistry results in
the formation of the products, sulfite and thiol.
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Currently, there is neither evidence that stored sulfane
sulfur is used in lieu of H2S for signaling nor mechanistic
insights into how its utilization might be regulated. The dis-
appearance of exogenous sulfide added to tissue homogena-
tes has been described as ‘‘absorption’’ of sulfide and
attributed to the formation of sulfane sulfur (27). However,
additional possibilities exist to explain the disappearance of
sulfide added to tissue homogenates including formation of
disulfides and other oxidation products and catabolism via
the mitochondrial oxidation pathway. The contributions of
these processes need to be assessed. Since alkaline conditions
favor the release of sulfane sulfur by physiological reductants
such as glutathione, it has been suggested that astrocytes
might be induced to release sulfane sulfur during repeated
neuronal excitation (Fig. 8A) (27). Under these conditions,
extracellular K + concentrations increase leading to depolar-
ization of astrocytes, activation of the Na +/HCO3
- co-
transporter and potentially, an increase in intracellular pH.
An increase in the intracellular pH by 0.56 units was recorded
in*60% of cultured astrocytes in the presence of 10mM K+ ,
of which 10% were more alkaline by 1.27 units. However, an
increase in released sulfide could not be detected in this ex-
periment and was attributed to the lack of sensitivity of the
assay method (27). Clearly, the existence and utilization of
general strategies for the regulated mobilization of sulfane
sulfur pools in various cell types need to be studied to address
the relevance of a storage pool to H2S signaling.
An underappreciated limitation with the concept of sulfane
sulfur as a storehouse for H2S is the chemical reactivity of this
post-translational modification. While the terminal sulfur in
persulfides has dual reactivity and can function both as an
electrophile and a nucleophile, the inner sulfur atom is elec-
trophilic. Thus, due to the inherent instability of persulfides,
stores if they exist, would have to be sequestered to have
reasonable lifetimes in the cellular milieu.
H2S-Based Signaling via Persulfidation
and Thionitrous Acid
While mechanisms for achieving specific persulfidation of
target proteins or for releasing sulfide from the sulfane sulfur
pool remain to be identified, the capacity for persulfidation to
modulate cellular function was demonstrated by early studies
by Vincent Massey on xanthine oxidase (44) and aldehyde
FIG. 8. Proposed models
for H2S-based signaling. (A)
Sulfane sulfur is reactive and
needs to be sequestered under
cellular conditions. Release of
H2S from persulfide is pro-
moted under alkaline condi-
tions and in the presence of a
reductant such as glutathione
(27). Alternatively, the sulfane
sulfur can be transferred to an
acceptor such as thioredoxin
from where it is released as
H2S with the concomitant
oxidation of thioredoxin. (B)
Formation of persulfide re-
quires oxidation of the target
protein to sulfenic acid or
disulfide followed by attack
of sulfide (32). Alternatively,
H2S2, the two-electron oxida-
tion product of H2S, can be
attacked by a protein thiolate
(59). (C) HSNO is formed by
the reaction of H2S and S-ni-
trosated protein. HSNO can
diffuse across the cell mem-
brane and serve as a source of
H2S or HNO depending on
the whether the nucleophile
attacks at the nitrogen or sul-
fur atom, respectively of
HSNO (15). HSNO, thioni-
trous acid.
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oxidase (6), both of which have an active site persulfide that is
essential for catalysis. In contrast, persulfide modification of
rat liver tyrosine aminotransferase, which is CSE-dependent,
leads to enzyme inactivation (23), and it is enhanced in ex-
perimental streptozotocin-induced diabetes (24). A crude
fractionation of liver and kidney homogenates in this exper-
iment indicated that sulfane sulfur exists in both low- and
high-molecular weight fractions.
A recent proteomic analysis of persulfidation revealed that
*10%–25% of liver proteins harbor this modification (53).
Transfection of HEK293 cells with CSE enhanced persulfida-
tion of three proteins that were monitored: glyceraldehyde 3-
phosphate dehydrogenase (GAPDH), b-tubulin, and actin.
However, the specificity of the modified biotin switch assay
used to block free thiols and detect persulfides might not in
fact have the required selectivity. Hence, caution needs to
be exercised during identification of persulfides with this
method. Persulfidation of GAPDH enhanced its activity while
the same modification on actin, increased polymerization.
Interestingly, S-nitrosylation and S-sulfhydration of GAPDH
occur at the same cysteine residue and elicit opposite effects
on catalytic activity (53), raising the possibility that the NO
and H2S signaling systems compete for reactive cysteines in
an overlapping set of target proteins.
The functional consequences of other proteins with per-
sulfide modification have been characterized (54, 66). First,
persulfidation of the antiapoptotic transcription factor,
NF-jB, enhances DNA binding and is stimulated by TNFa,
which increases H2S production via SP1-mediated transcrip-
tional activation of CSE (66). The modified cysteine in the
p65 subunit of NF-jB is targeted by S-nitrosylation and
S-sulhydration with opposing functional effects. Second,
persulfidation of the ATP-sensitive K+ channel causes hy-
perpolarization and vasorelaxation of rodent mesenteric
arteries suggesting that H2S is an endothelium-derived hy-
perpolarizing factor (54). Third, persulfidation of protein
tyrosine phosphatase, PTP1B inhibited its activity and pro-
moted the activity of PERK in response to ER stress (40).
Despite the growing number of protein targets being iden-
tified whose functions are influenced by persulfide modifica-
tion, little attention has been paid to the mechanism by which
H2S can modify cysteine residues. In the reducing intracellular
milieu, cysteines are likely to exist predominantly in the thiol
form,which is unreactive toH2S. Transient increases in reactive
oxygen species concentration in response to triggers such as
growth factor or cytokine signaling would increase the pro-
portion of cysteines present in oxidized forms, for example,
sulfenic acid and disulfides, both of which are reactive to H2S
(Fig. 8B). Hydrogen persulfide, formed by two-electron oxi-
dation of H2S, has been proposed as a possible cellular sulf-
hydration reagent (59). Alternatively, cellular alkanization
leading to release of H2S from persulfide or more plausibly,
activating the catalytic transfer of sulfane sulfur from seques-
tered ‘‘storage’’ sites to target proteins, for example, via the
activity of thioredoxin, could result in persulfidation (Fig. 8A).
This thioltransferase mechanism does not depend on prior
oxidation of reactive cysteines on target proteins.
In light of the lack of emphasis on mechanisms underlying
H2S-based protein modification, the recent discovery of
thionitrous acid (HSNO), formed by reaction between H2S
and S-nitrosothiols, is exciting (Fig. 8C) (15). HSNO can freely
diffuse across membranes, connecting the intra- and extra-
cellular signalingmilieus, and can be a source of NO+ (during
protein S-nitrosylation), NO or HNO species, each with the
potential for eliciting distinct physiological responses. Using a
nitroxyl-sensitive fluorescent dye, strong evidence was ob-
tained for the intracellular generation of HNO in endothelial
cells. Formation of nitrosothiol from the reaction between H2S
and NO or peroxynitrite (ONOO - ) was previously inferred
and speculated to be important in blunting the effect of NO
(92). The discovery of HSNO expands the repertoire of redox-
sensitive signaling molecules and provides a mechanism for
crosstalk between the NO and H2S gas signaling pathways.
This discovery explains the synergistic effect of H2S and NO
on smooth muscle relaxation noted previously (26). The ex-
istence of HSNO raises questions about whether its formation
is regulated by coupling of the activities of H2S-producing
enzymes and NO synthase (15).
Summary
In these early days in the field of H2S biochemistry and
signaling there aremore questions than answers, representing
an exciting place for the convergence of chemists, biochemists,
and cell biologists. While a multitude of reactions yielding
H2S catalyzed by the trans-sulfuration pathway enzymes
have been identified (11, 71), there is little understanding of
how the catalysts switch between the canonical and H2S-
generating reactions. Further, the quantitative significance of
the three catalysts, CBS, CSE, and MST for H2S production in
different tissues needs to established using carefully designed
assays that do not bias against the contributions of any en-
zyme. Similarly, critical questions remain unanswered re-
garding the enzymology of sulfide and persulfide oxidation
including fundamental ones such as what is the physiological
persulfide acceptor for SQR and the persulfide donor for
ETHE1? While the activities of SQR and ETHE1 either indi-
rectly or directly depend on oxygen thus lending them sus-
ceptible to hypoxic conditions, it is not known what other
effectors might regulate them. Finally, the chemistry of the
H2S-based signaling itself is mired in chemical complexity
contributed in part by the experimental challenges with
working with a redox-active gaseous signaling molecule and
by its potential for interacting with the NO and CO signaling
pathways. The resolution of these and other mechanistic
questions pertinent to H2S homeostasis and signaling will be
critical for moving the field ahead in the coming years.
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